ResearcherUmeå UniversityActive in the last 2 years

Parniyan Maneshi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2180-4097; OpenAlex author ID A5001974350. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

Dissecting FAP+ Cell Diversity in Pancreatic Cancer Uncovers an Interferon-Response Subtype of Cancer-Associated Fibroblasts with Tumor-Restraining Properties. First author DOI 10.1158/0008-5472.can-23-3252 ↗
Targeting Tumor-Stromal Interactions in Pancreatic Cancer: Impact of Collagens and Mechanical Traits. Co-author DOI 10.3389/fcell.2021.787485 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Daniel Öhlund · 2 shared papers, 2021–2025 · strength 0.45
- Paper Dissecting FAP+ Cell Diversity in Pancreatic Cancer Uncovers an Interferon-Response Subtype of Cancer-Associated Fibrob… DOI 10.1158/0008-5472.can-23-3252 ↗
- Paper Targeting Tumor-Stromal Interactions in Pancreatic Cancer: Impact of Collagens and Mechanical Traits. DOI 10.3389/fcell.2021.787485 ↗
Joshua Cumming · 1 shared paper, 2025 · strength 0.26
- Paper Dissecting FAP+ Cell Diversity in Pancreatic Cancer Uncovers an Interferon-Response Subtype of Cancer-Associated Fibrob… DOI 10.1158/0008-5472.can-23-3252 ↗
James E. Mason · 1 shared paper, 2021 · strength 0.19
- Paper Targeting Tumor-Stromal Interactions in Pancreatic Cancer: Impact of Collagens and Mechanical Traits. DOI 10.3389/fcell.2021.787485 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.